Murat Arcasoy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Arcasoy is currently accepting new patients.

I have the privilege of caring for patients with various myeloproliferative neoplasms including, polycythemia vera, essential thrombocytosis, primary myelofibrosis, systemic mastocytosis, and chronic myeloid leukemia. My goal is to provide the best possible care for each individual patient in an era where the number of therapeutic options for patients with myeloproliferative neoplasms is rapidly expanding. As a clinical investigator leading several clinical studies in both early and late stages of development, I strive to offer patients access to investigational agents with novel mechanisms of action via participation in clinical trials. I believe that every patient has a unique diagnosis and personal experience with their cancer. I aim to consider the disease, the patient and individual care goals in partnering with patients to develop and implement personalized treatment plans. Dr. Rein is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

Robin Hardie is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Hardie has been practicing medicine for over 27 years and is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Colorectal Cancer.

I primarily see patients who have a variety of rare bleeding and clotting disorders. I see both older and younger patients and also provide help when patients need to transition to and away from blood thinners. Doctors usually refer patients to me. I try to work with each patient so they understand why they are seeing me and what is going on with their body. I enjoy when a patient can leave my office with a complete understanding of what is going on and what they need to do to get better. As a young child, I had bad allergies and spent much time in the doctor’s office. As a frequent patient, I enjoyed spending time around medicine. As I entered college, I found that I enjoyed chemistry and that hematology allowed me to combine lab work with patient care. Dr. Ortel is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Thrombocytopenia, Deep Vein Thrombosis, and Thalamotomy.

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.

I have over twenty years of experience as a hematologist-oncologist focusing in hematologic malignancies, leukemias, lymphomas, myeloma, and myelodysplastic and myeloproliferative syndromes. My patient care philosophy stresses interactive discussions with patients and their families on what to expect from the illness and treatment options, making sure that all their concerns and questions are addressed. Caring for patients with cancer is complex and my care team is dedicated to helping patients with the family, social, emotional, and financial issues, in addition to compassionate medical care. Dr. Kirby is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, and Bone Marrow Aspiration.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. Decastro is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Richard Lopez is a Transplant Surgeon in Durham, North Carolina. Dr. Lopez has been practicing medicine for over 36 years and is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Gowthami Arepally is a Hematologist in Durham, North Carolina. Dr. Arepally has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).

Sandy El Bitar is a Hematologist in Durham, North Carolina. Dr. El Bitar has been practicing medicine for over 12 years and is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Febrile Neutropenia, Agranulocytosis, Chronic Familial Neutropenia, and Essential Thrombocythemia.

Oluwatoyosi Onwuemene is a Hematologist in Durham, North Carolina. Dr. Onwuemene has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Thrombocytopenia, Pulmonary Embolism, Blood Clots, Sickle Cell Disease, and Bone Marrow Aspiration.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.

Gwynn Long is a Transplant Surgeon in Durham, North Carolina. Dr. Long has been practicing medicine for over 42 years and is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Colonoscopy.

As a blood cancer specialist and also a palliative care physician, I bring a different focus to cancer care. I’m working hard to improve the treatment experience for patients who are living with blood cancers. By understanding your experience better, we can develop new ways to improve your quality of life, and provide additional support throughout your treatment and beyond. Dr. Leblanc is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

I focus on treating patients with blood cancers who are considering stem cell or bone marrow transplantation. There have been significant improvements in transplantation over the last 20 years, which has improved outcomes. These improvements include the ability to use lower doses of chemotherapy to reduce toxicity for patients, as well as strategies to reduce the risk of relapse. I am interested in using new therapies and approaches to improve outcomes after stem cell transplantation for blood cancers. It is important to work together with patients to determine their goals for treatment and select the best path forward. I have enjoyed working with patients and their families for many years after their transplant. Dr. Alyea is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Transplant.

Nothing gives me more satisfaction than when I care for people. I try to give patients and families an experience that makes them feel safe and secure. I chose oncology because when I was 19 my father died from lung cancer. I felt so helpless because I did not know what was happening and did not feel like the bedside care was appropriate during that challenging time. It was at that time that I decided to pursue a career as a nurse practitioner. I wanted to be a person that could provide the security and compassion that patients and families need when they get a cancer diagnosis. Ms. Smith is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myeloproliferative Neoplasms (MPN) and Paroxysmal Nocturnal Hemoglobinuria (PNH).

I specialize in leukemia, myeloid neoplasm, adult bone marrow transplantation, and cellular therapies. I have been inspired by many patients and their loved ones going through the challenging journey to cure underlying leukemia and myeloid neoplasms and feel very privileged to serve them. I am dedicated to clinical research that aims to expand access to bone marrow transplantation and cellular therapies. I am passionate about improving the outcomes of adult bone marrow transplant patients by preventing the relapse of leukemia. In order to do this, we are developing a comprehensive machine learning algorithm to predict relapse after transplantation. I strive to make a meaningful difference in the treatment of patients with hematologic malignancies. Dr. Hong is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.